View in EDS

Azeliragon attenuates cerebral infarction aggravation in diabetic rats: Receptor for advanced glycation end-product as a novel therapeutic target.

Saved in:
Bibliographic Details
Title: Azeliragon attenuates cerebral infarction aggravation in diabetic rats: Receptor for advanced glycation end-product as a novel therapeutic target.
Authors: Lee JS; Department of Neurology, Ajou University School of Medicine, Ajou University Hospital, Republic of Korea. Electronic address: jinsoo22@gmail.com., Yoon BS; Department of Neurology, Ajou University School of Medicine, Ajou University Hospital, Republic of Korea., Lee SJ; Department of Neurology, Ajou University School of Medicine, Ajou University Hospital, Republic of Korea., Park SY; Department of Neurology, Ajou University School of Medicine, Ajou University Hospital, Republic of Korea., Joe EH; Department of Pharmacology, Ajou University School of Medicine, Suwon, Republic of Korea., Oh YJ; Institute for Convergence Research and Education in Advanced Technology, Yonsei University, Incheon, Republic of Korea; GNT Pharma Science and Technology Center for Health, Incheon, Republic of Korea., Choi EJ; GNT Pharma Science and Technology Center for Health, Incheon, Republic of Korea; Division of Life Sciences, College of Life Sciences, Korea University, Seoul, Republic of Korea.
Source: Experimental neurology [Exp Neurol] 2026 Mar; Vol. 397, pp. 115588. Date of Electronic Publication: 2025 Dec 09.
Publication Type: Journal Article
Journal Info: Publisher: Academic Press Country of Publication: United States NLM ID: 0370712 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2430 (Electronic) Linking ISSN: 00144886 NLM ISO Abbreviation: Exp Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1090-2430
DOI:10.1016/j.expneurol.2025.115588